Olorofim demonstrates in vitro activity against Coccidioides species, including isolates against which fluconazole

Nathan P Wiederhold1,2, Hoja P Patterson1, Dora Ferrer1

  • 1Fungus Testing Laboratory, Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

PubMed

Insights

Olorofim shows strong in vitro antifungal activity against Coccidioides species. This potent activity was effective even against fungal isolates resistant to fluconazole.

Area of Science:

  • Mycology
  • Antifungal Research
  • Infectious Diseases

Background:

  • Coccidioides species are pathogenic fungi causing coccidioidomycosis.
  • Antifungal resistance is a growing concern in treating fungal infections.
  • Limited treatment options exist for severe or refractory coccidioidomycosis.

Purpose of the Study:

  • To evaluate the in vitro antifungal activity of olorofim against various Coccidioides species.
  • To determine the minimum inhibitory concentrations (MICs) of olorofim.
  • To assess olorofim's efficacy against fluconazole-resistant Coccidioides isolates.

Main Methods:

  • In vitro susceptibility testing was performed on Coccidioides isolates.
  • Minimum Inhibitory Concentrations (MICs) were determined for olorofim.
  • Isolates with known elevated fluconazole MICs were specifically included.

Main Results:

  • Olorofim exhibited potent in vitro activity against all tested Coccidioides isolates.
  • The geometric mean MIC for olorofim was as low as 0.010 µg/mL.
  • Olorofim maintained potent activity against isolates with high-level fluconazole resistance (MICs ≥16 µg/mL and ≥32 µg/mL).

Conclusions:

  • Olorofim demonstrates significant in vitro potency against Coccidioides species.
  • Olorofim is a promising candidate for treating coccidioidomycosis, including fluconazole-resistant cases.
  • Further clinical investigation of olorofim for coccidioidomycosis is warranted.